Status:

COMPLETED

Physiologic Effects of High-flow Nasal Cannula Versus Standard Oxygen Therapy Postextubation in Critically Ill Patients

Lead Sponsor:

Pontificia Universidad Catolica de Chile

Collaborating Sponsors:

Fondo Nacional de Desarrollo Científico y Tecnológico, Chile

Conditions:

Ventilator Weaning

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

High-flow nasal cannula (HFNC) is a rather novel system to provide oxygen therapy, which provides flows up to 60 liters/minute (LPM) of heated and humidified gas through nasal prongs. HFNC is increasi...

Eligibility Criteria

Inclusion

  • Mechanical ventilation (MV) through an orotracheal tube for at least 48 hours
  • PaO2 /FiO2 ratio ≤ 300 mmHg
  • Potential for weaning as determined in routine daily screening (precipitating cause leading to MV in resolution, adequate oxygenation (PaO2/FiO2 ≥150 mmHg with FiO2 ≤0.4 and PEEP ≤8 cm H2O), arterial pH \>7.25, hemodynamic stability (no vasopressors or Noradrenaline ≤0.1 mcg/kg/min), temperature \<38°C, presence of inspiratory effort and appropriate spontaneous cough, and the patient is not receiving sedatives and is awake and able to follow simple commands)
  • Decision to perform a spontaneous breathing trial by the attending physician

Exclusion

  • Patients ventilated for decompensated chronic obstructive pulmonary disease
  • Contraindications to HFNC, which include abnormalities or surgery of the face, nose, or airway that preclude an appropriate-fitting nasal cannula.
  • Contraindications for esophageal balloon catheter insertion (eg. severe coagulopathy, esophageal varices, and history of esophageal or gastric surgery)
  • Contraindication for use of electric impedance tomography (eg. Pacemaker)
  • Presence of tracheostomy
  • Refusal to participate by the attending physician
  • Do not resuscitate order

Key Trial Info

Start Date :

January 27 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 17 2022

Estimated Enrollment :

26 Patients enrolled

Trial Details

Trial ID

NCT04711759

Start Date

January 27 2021

End Date

December 17 2022

Last Update

January 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Clínico UC Christus

Santiago, Santiago Metropolitan, Chile, 114D